Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study - Matulonis, Ursula A.; Lorusso, Domenica; Oaknin, Ana; Pignata, Sandro; Dean, Andrew; Denys, Hannelore; Colombo, Nicoletta; Van Gorp, Toon; Konner, Jason A.; Marin, Margarita Romeo; Harter, Philipp; Murphy, Conleth G.; et al. (Journal of clinical oncology, 2023)
Keywords: Adenosine Diphosphate Ribose - therapeutic use; Antineoplastic Agents - therapeutic use; Bevacizumab - therapeutic use; Carcinoma, Ovarian Epithelial - drug therapy; Female; Folate Receptor 1 - therapeutic use; Humans; Immunoconjugates - adverse effects; ORIGINAL REPORTS; Ovarian Neoplasms - drug therapy; Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use